Detection of p16 promoter methylation in premature rats with chronic lung disease induced by hyperoxia

被引:7
作者
Yue, Xiaohong [1 ]
Fu, Jianhua [1 ]
Xue, Xindong [1 ]
Gao, Hong [2 ]
Liu, Dongyan [2 ]
Zong, Zhihong [3 ]
Wang, Wei [2 ]
Li, Hui [2 ]
Yuan, Zhengwei [2 ]
机构
[1] China Med Univ, Dept Pediat, Shengjing Hosp, Shenyang 110004, Peoples R China
[2] China Med Univ, Centralab, Shengjing Hosp, Shenyang 110004, Peoples R China
[3] China Med Univ, Biochem & Mol Biol Lab, Shenyang 110004, Peoples R China
关键词
chronic lung disease; hyperoxia; methylation; GENE PROMOTER; ABERRANT METHYLATION; DNA METHYLATION; EARLY EVENT; HYPERMETHYLATION; EXPRESSION; CANCER; P16(INK4A); LESIONS; REGION;
D O I
10.1111/j.1442-200X.2010.03089.x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: The aim of the present study was to investigate p16 promoter methylation in premature rats with chronic lung disease (CLD) induced by hyperoxia. Methods: Eighty Wistar rats were randomized into the hyperoxia group (fraction of inspired oxygen [FiO(2)] = 900 mL/L) or the control group (FiO(2) = 210 mL/L), 40 for each group. Semi-nested methylation-specific polymerase chain reaction (sn-MSP) was applied to detect p16 promoter hypermethylation in lung tissues. Additionally, p16 mRNA and protein expression was detected on reverse transcription-polymerase chain reaction (RT-PCR), western blot and the strept actividin-biotin complex method. Results: Extended exposure to hyperoxia led to increased methylation, and the methylation level reached a peak in the period of maximum pulmonary fibrosis in the hyperoxia group, while the methylation did not occur in the control group. The methylation rates on semi-nested PCR (sn-PCR) and nested-MSP were, respectively, 52.5% and 42.5% in the hyperoxia group. There was no statistically significant difference between the two methods. The p16 mRNA and protein expression was significantly higher in those with p16 promoter hypermethylation than those without. Conclusion: Exposure to hyperoxia may induce p16 promoter hypermethylation in lung tissues in premature rats, and methylation risk increases as exposure extends. p16 promoter methylation induced by hyperoxia may be one of the mechanisms for low p16 mRNA and protein expression.
引用
收藏
页码:520 / 526
页数:7
相关论文
共 50 条
  • [21] Promoter methylation of p16 and EDNRB gene in leukemia patients in Taiwan
    Hsiao, Pei-Ching
    Liu, Min-Chang
    Chen, Li-Mien
    Tsai, Ching-Yi
    Wang, Yu-Ting
    Chen, Jung
    Hsu, Li-Sung
    CHINESE JOURNAL OF PHYSIOLOGY, 2008, 51 (01): : 27 - 31
  • [22] Correlation between methylation of the p16 promoter and cervical cancer incidence
    Wang, F. -L.
    Yang, Y.
    Liu, Z. -Y.
    Qin, Y.
    Jin, T.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2017, 21 (10) : 2351 - 2356
  • [23] 5-aza-2′-deoxycytidine, a DNA methylation inhibitor, attenuates hyperoxia-induced lung fibrosis via re-expression of P16 in neonatal rats
    Zhao, Shi-meng
    Wu, Hong-min
    Cao, Mei-ling
    Han, Dan
    PEDIATRIC RESEARCH, 2018, 83 (03) : 723 - 730
  • [24] Aberrant p16 promoter methylation among Greek lung cancer patients and smokers:: correlation with smoking
    Georgiou, Elisavet
    Valeri, Rozalia
    Tzimagiorgis, Georgios
    Anzel, Jacob
    Krikelis, Dimitrios
    Tsilikas, Christos
    Sarikos, Georgios
    Destouni, Chara
    Dimitriadou, Afroditi
    Kouidou, Sofia
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2007, 16 (05) : 396 - 402
  • [25] p16 promoter methylation in Pb2+-exposed individuals
    Leda, Kovatsi
    Elisavet, Georgiou
    Antrea, Ioannou
    Costas, Haitoglou
    George, Tzimagiorgis
    Helen, Tsoukali
    Sofia, Kouidou
    CLINICAL TOXICOLOGY, 2010, 48 (02) : 124 - 128
  • [26] Global methylation and promoter-specific methylation of the P16, SOCS-1, E-cadherin, P73 and SHP-1 genes and their expression in patients with multiple myeloma during active disease and remission
    Martinez-Banos, Deborah
    Sanchez-Hernandez, Beatriz
    Jimenez, Guadalupe
    Barrera-Lumbreras, Georgina
    Barrales-Benitez, Olga
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 13 (05) : 2442 - 2450
  • [27] CDKN2A (p16) Promoter Hypermethylation Influences the Outcome in Young Lung Cancer Patients
    Bradly, Dawn P.
    Gattuso, Paolo
    Pool, Mark
    Basu, Sanjib
    Liptay, Michael
    Bonomi, Philip
    Buckingham, Lela
    DIAGNOSTIC MOLECULAR PATHOLOGY, 2012, 21 (04) : 207 - 213
  • [28] P16 Methylation Leads to Paclitaxel Resistance of Advanced Non-Small Cell Lung Cancer
    Liu, Zhaojun
    Lin, Hongmei
    Gan, Ying
    Cui, Chenghua
    Zhang, Baozhen
    Gu, Liankun
    Zhou, Jing
    Zhu, Guangying
    Deng, Dajun
    JOURNAL OF CANCER, 2019, 10 (07): : 1726 - 1733
  • [29] METHYLATION PROFILE OF PROMOTER REGION OF p16 GENE IN COLORECTAL CANCER PATIENTS OF KASHMIR VALLEY
    Wani, H. A.
    Beigh, M. A.
    Amin, S.
    Bhat, A. A.
    Bhat, S.
    Khan, H.
    Naikoo, N. A.
    Farooq, R.
    Showkat, M.
    Masood, A.
    Majid, S.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2013, 27 (02) : 297 - 307
  • [30] Human papillomavirus detection and p16 methylation pattern in a case of esophageal papilloma
    Afonso, L. A.
    Moyses, N.
    Cavalcanti, S. M. B.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2010, 43 (07) : 694 - 696